Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan

Breast Cancer

Volumn 11, Issue 1, 2004, Pages 30-32

  Takeda, Motohiro ^a   Ishida, Takanori ^a   Ohnuki, Kohji ^a   Suzuki, Akihiko ^a   Sakayori, Masato ^a   Ishioka, Chikashi ^a   Nomizu, Tadashi ^b   Noguchi, Shinzaburou ^c   Matsubara, Yoichi ^a   Ohuchi, Noriaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOSHI GENERAL HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BRCA1; BRCA2; Familial breast cancer; Hereditary breast cancer

Indexed keywords

ARTICLE; BREAST TUMOR; CANCER CENTER; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; HUMAN; JAPAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; ONCOLOGY SERVICE, HOSPITAL;

EID: 1542379875     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967998     Document Type: Article

References (11)

1. Lynch HT, Lynch JF: Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet 22:369-371, 1986. (Pubitemid 16012080)
2. Ikeda N, Miyoshi Y, Yoneda K: Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83-88, 2001.
3. Noguchi S, Kasugai T, Mild Y, Fukutomi T: Clinicopathologic analysis of BRCA1-or BRCA2-associated hereditary breast carcinoma in Japanese women. Cancer 85:2200-2205, 1999. (Pubitemid 29215559)
4. Neuhausen S, Gilewsld T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128, 1996.
5. Hartmann LC, Schaid D J, Woods JE: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84, 1999. (Pubitemid 29054841)
6. Moller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, Anderson E, Steel CM, Apold J, Goudie D, Howell A, Lalloo F, Maehle L, Gregory H, Heimdal K: Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer 101:555-559, 2002.
7. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Eng J Med 346:1616-1622, 2002. (Pubitemid 34755669)
8. Contant CM, Menke-Pluijmers MB, Seynaeve C: Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur J Surg Onco1 28:627-632, 2002.
9. Fisher B, Costantino JP: Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 91:1891A-1892, 1999.
10. Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesald N, Satoh S, Enomoto T, Motoyama S, Tanaka K: Mutational analysis of ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7:3144-3150, 2001.
11. Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, Massuger LF, Boetes C, Manders P, Brunner HG: High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Onco1 21:41-45, 2003.